De Marinis Grasso, Laura
 Distribuzione geografica
Continente #
EU - Europa 4.658
NA - Nord America 3.820
AS - Asia 1.349
AF - Africa 14
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 9.864
Nazione #
US - Stati Uniti d'America 3.788
DE - Germania 2.024
SE - Svezia 793
CN - Cina 622
UA - Ucraina 546
IT - Italia 370
SG - Singapore 355
IE - Irlanda 217
FR - Francia 206
GB - Regno Unito 163
ID - Indonesia 132
FI - Finlandia 120
IN - India 119
RU - Federazione Russa 103
BE - Belgio 45
TR - Turchia 40
CA - Canada 30
JP - Giappone 26
HK - Hong Kong 18
NL - Olanda 16
IR - Iran 10
VN - Vietnam 10
CH - Svizzera 9
CI - Costa d'Avorio 8
RO - Romania 7
PL - Polonia 6
CZ - Repubblica Ceca 5
ES - Italia 5
AU - Australia 4
BR - Brasile 4
CO - Colombia 4
LT - Lituania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CL - Cile 3
IL - Israele 3
KR - Corea 3
MD - Moldavia 3
NG - Nigeria 3
PE - Perù 3
PT - Portogallo 3
AL - Albania 2
CR - Costa Rica 2
EU - Europa 2
HU - Ungheria 2
IQ - Iraq 2
NO - Norvegia 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BG - Bulgaria 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
KW - Kuwait 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
ME - Montenegro 1
MY - Malesia 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
Totale 9.864
Città #
Chandler 847
Singapore 273
Jacksonville 218
San Mateo 214
Dublin 208
Ann Arbor 206
Ashburn 206
Nanjing 148
Jakarta 132
Wilmington 126
New York 125
Boston 99
Nürnberg 98
Marseille 89
Dearborn 79
Moscow 78
Houston 70
Woodbridge 69
Milan 66
Princeton 65
Rome 59
Beijing 54
Cattolica 52
Lawrence 52
Redwood City 51
Nanchang 50
Chicago 49
Bremen 48
Munich 48
Los Angeles 44
Brussels 43
Mountain View 43
Seattle 43
University Park 40
Zhengzhou 39
Hangzhou 35
Boardman 34
Izmir 34
Delhi 33
Detroit 33
Fairfield 31
Norwalk 28
Shenyang 28
Helsinki 27
Lancaster 27
Shanghai 27
Fremont 26
Leawood 22
Changsha 21
Hebei 20
Kunming 20
Redmond 19
Tianjin 18
Hong Kong 17
Jiaxing 17
Cambridge 15
Guangzhou 15
Augusta 11
Brescia 11
Jinan 11
Falls Church 10
Hanoi 10
Pune 10
Renton 10
Toronto 10
Ningbo 9
Ottawa 9
Paris 9
Philadelphia 9
Santa Clara 9
Simi Valley 9
Abidjan 8
Indiana 8
Washington 8
Piacenza 7
Canterbury 6
Changchun 6
Kish 6
Lanzhou 6
Mumbai 6
Windsor 6
Andover 5
Menlo Park 5
Amsterdam 4
Bari 4
Bergamo 4
Edinburgh 4
Gunzenhausen 4
Hefei 4
London 4
Palermo 4
Prineville 4
West Jordan 4
Zurich 4
Atlanta 3
Auburn 3
Brno 3
Chisinau 3
Coimbatore 3
Costa Mesa 3
Totale 4.954
Nome #
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 233
The treatment of neuroendocrine tumors with long-acting somatostatin analogs: A single center experience with lanreotide autogel 219
Evaluation of antioxidants systems in pituitary-adrenal axis diseases. 199
Double pituitary adenomas 191
Predictors of morbidity and mortality in acromegaly, an Italian survey. 187
Growth hormone in inflammatory bowel disease 183
Seminal antioxidant capacity in pre- and postoperative varicocele 163
Evaluation of Antioxidant systems (Coenzyme Q10 and total antioxidant capacity) in morbidy obesity before and after biliopancreatic diversion 153
Male fertility and reduction in semen parameters: A single tertiary-care center experience 152
Coenzyme Q10 evaluation in pituitary-adrenal axis disease: preliminary data. 149
Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis 141
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 140
Xanthogranuloma of the sellar region: A rare tumor. Case illustration and literature review 136
Effects of gherlin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 133
Relationships between plasma CoQ10 levels and thyroid hormones in chronic obstructive pulmonary disease. 130
An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Single Prospective Monocentric Experience 130
Increased estradiol levels in venous occlusive disorder: a possible functional mechanism of venous leakage. 127
NOVEL BIOMARKERS OF ANDROGEN DEFICIENCY FROM SEMINAL PLASMA PROFILING USING HIGH-RESOLUTION MASS SPECTROMETRY. 127
Circulating endothelial cells as marker of endothelial damage in male hypogonadism 122
Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography. 121
Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control study 119
Hypotestosteronemia is frequent in ST-elevation myocardial infarction patients and is associated with coronary microvascular obstruction 110
Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography 110
Primary hyperparathyroidism. Our experience 108
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study 108
Hypothalamitis: a diagnostic and therapeutic challenge 106
Circulating endothelial cells as marker of endothelial damage in male hypogonadism 106
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 105
Isolated growth hormone deficiency: clinical entity? 104
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly. 103
Influence of diabetes mellitus on vertebral fractures in men with acromegaly 103
[Immunogenetic and functional study of first-degree relatives of patients with type I diabetes mellitus for identifying prediabetic subjects] 102
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 100
Radically resected pituitary adenomas: prognostic role of Ki67 labeling index in monocentric retrospective series and literature review 100
Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas. 99
The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature 96
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes 96
Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 94
Proteomic approach in the identification of fertility pattern in seminal plasma of fertile men 94
Fertility and hypopituitarism 93
Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients. 93
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: An immunohistochemical study 93
Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade 91
[Coexistence of hyperthyroidism and thyroid carcinoma. Description of a clinical case] 91
Significant GH-deficiency after long-term cure by surgery in adult patients with Cushing s disease 91
Naloxone inhibition of postprandial growth hormone releasing hormone-induced growth hormone release in obesity 90
Pancreatic metastases from a bronchopulmonary carcinoid diagnosed by endoscopic ultrasonography-guided fine-needle tissue acquisition 89
Hypopituitarism findings in patients with primary brain tumors 1 year after neurosurgical treatment: preliminary report. 86
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second Line Therapies: A Longitudinal Study 86
Hypotestosteronemia is frequent in ST-elevation myocardial infarction patients and is associated with coronary microvascular obstruction 84
GH receptor isoforms and skeletal fragility in acromegaly 84
Hormonal and metabolic evaluation in Down's syndrome: preliminary evidence for TSH dysregulation in hyperthyrotropinemic patients 83
Effects of Testosterone on antioxidant systems in male secondary hypogonadism. 82
Increased total antioxidant capacity in seminal plasma of varicocele patients: a multivariate analysis 80
Endocrine status in patients with mammary gland diseases: correlation between steroid hormones and sex steroid binding globulin 80
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 80
ACTH-dependent Cushing syndrome: The potential benefits of simultaneous bilateral posterior retroperitoneoscopic adrenalectomy 78
DIAGNOSIS OF ENDOCRINE DISEASE: Primary Empty Sella: a comprehensive review 77
The treatment of hyperinsulinemic hypoglycaemia in adults: an update 76
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency 71
Prevalence of vertebral fractures in men with acromegaly 71
High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas 70
Reciprocal regulation of microrna-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions 70
Corticotropin-releasing hormone inhibition of gonadotropin secretion during the menstrual cycle 69
Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU. 68
Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly. 68
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. 67
Synchronous Bilateral Adrenalectomy in ACTH-dependent Hypercortisolism: Predictors, Biomarkers and Outcomes 67
The exon 3-deleted growth hormone receptor: Molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions 66
Endocrine evaluation of patients with benign lumps of the breast 65
Vertebral fractures in patients with acromegaly: a 3-year prospective study 63
Prolactin dynamics in normoprolactinemic primary empty sella: correlation with intracranial pressure 62
Clinical management of teratoma, a rare hypothalamic-pituitary neoplasia 62
Primary empty sella: Why and when to investigate hypothalamic-pituitary function 61
Plasma prolactin response to gonadotropin-releasing hormone during benzodiazepine treatment 60
ACROSTUDY: the Italian experience 60
Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in caucasian patients 60
The changing clinical spectrum of endocrine adverse events in cancer immunotherapy 60
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 59
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 57
Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA 56
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors. 56
An update of Coenzyme Q10 implications in male infertility: biochemical and therapeutic aspects. 55
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients: A multicenter study 54
Vertebral fractures in males with prolactinoma. 54
Endocrine evaluation of patients with benign lumps of the breast 54
Endocrine status in patients with mammary gland diseases: correlation between steroid hormones and sex steroid binding globulin 54
Empty sella syndrome: Multiple endocrine disorders. 54
The Role of Growth Hormone Receptor Isoforms and Their Effects in Bone Metabolism and Skeletal Fragility 54
Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. 52
Understanding the effect of acromegaly on the human skeleton. 51
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 50
Pituitary-tumour-transforming-gene 1 expression in testicular cancer 49
Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism. 49
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. 49
Effects of high-dose octreotide lar on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy 48
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 48
Autoantibody reactivity profile of primary autoimmune hypophysitis patients: preliminary results 48
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs. 46
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion. 45
Totale 9.188
Categoria #
all - tutte 40.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.897


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020902 0 0 0 0 84 111 248 65 79 74 142 99
2020/2021957 36 103 13 106 117 57 119 22 109 106 157 12
2021/20221.163 60 96 20 79 112 45 26 175 50 66 183 251
2022/20232.397 302 346 194 337 172 283 135 183 266 42 77 60
2023/20241.052 61 319 21 43 51 163 37 19 28 34 118 158
2024/2025545 63 63 170 81 168 0 0 0 0 0 0 0
Totale 10.047